KCM
SGMO

Karp Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Karp Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,000
Closed -$16K – 388
2015
Q1 		$16K Buy
+1,000
New +$15.5K 0.01% 266

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Karp Capital Management's SGMO Position: Q2 2015 in Review

Karp Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 1,000 shares — an estimated $16K sold.

Karp Capital Management first reported a position in SGMO in Q1 2015 and held it in 1 quarter. The position peaked at $16K in Q1 2015. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Karp Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Karp Capital Management sold 1,000 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $16K.
  • Karp Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 1 quarter.
  • Karp Capital Management's SANGAMO THERAPEUTICS INC position peaked at $16K in Q1 2015.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Karp Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.